Sana Biotechnology, Inc.SANANASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | -41.07% |
| Q3 2025 | -16.97% |
| Q2 2025 | 2.24% |
| Q1 2025 | 16.54% |
| Q4 2024 | -29.60% |
| Q3 2024 | 44.88% |
| Q2 2024 | -65.14% |
| Q1 2024 | 35.25% |
| Q4 2023 | 510.75% |
| Q3 2023 | -117.05% |
| Q2 2023 | 48.21% |
| Q1 2023 | 15.08% |
| Q4 2022 | -17.27% |
| Q3 2022 | 29.41% |
| Q2 2022 | 216.57% |
| Q1 2022 | -82.50% |
| Q4 2021 | 40.86% |
| Q3 2021 | 325.59% |
| Q2 2021 | -118.37% |
| Q1 2021 | 62.25% |
| Q4 2020 | 133.73% |
| Q3 2020 | -45.61% |
| Q2 2020 | 199.77% |
| Q1 2020 | -30.44% |
| Q4 2019 | 0.00% |